Physician

Cynthia L Shepherd, MD

According to 2025 Medicare claims, Cynthia Shepherd, MD (NPI: 1730236688) practices hematology/oncology in the Athens-Clarke County, GA market, with the plurality of this provider's patient population coming from Clarke, GA. This provider's primary affiliated billing organization is UNIVERSITY CANCER & BLOOD CENTER LLC (NPI: 1346343761; TIN: 20-1842623) and primary practice location at 30607-1465. Shepherd is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Shepherd's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 805 traditional Medicare patients, billed 192,082 HCPCS/CPT codes, and received $3,774,638 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,046 prescription claims across 343 beneficiaries totaling $3,460,387 in drug costs, led by Procrit (Epoetin Alfa). DME data shows 14 claims. Open Payments data shows 20 records totaling $11,270. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,985,375 to $3,774,638. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,130,881 to $3,460,387. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $10,061 to $88,884.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	922	197,158	$1,985,375
2016	881	200,407	$2,083,350
2017	943	220,513	$2,920,807
2018	849	232,484	$2,998,949
2019	784	185,304	$3,022,973
2020	846	176,909	$3,006,392
2021	1,007	223,167	$4,123,568
2022	798	186,181	$3,471,139
2023	806	183,110	$3,404,928
2024	805	192,082	$3,774,638

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	291	1,826	$1,130,881
2016	277	1,790	$1,201,329
2017	282	1,589	$1,752,285
2018	291	1,607	$1,697,263
2019	281	1,556	$2,170,492
2020	292	1,518	$2,776,888
2021	358	2,015	$4,413,635
2022	382	2,228	$3,916,080
2023	339	2,189	$4,328,207
2024	343	2,046	$3,460,387

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	269	$56,354
2016	11	170	$16,617
2017	N/R	98	$11,705
2018	N/R	82	$11,456
2019	41	113	$8,710
2020	24	124	$8,388
2021	N/R	119	$7,742
2022	N/R	109	$4,556
2023	N/R	71	$9,340
2024	N/R	14	$769

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	633	2,134	$89
36415	Insertion of needle into vein for collection of blood sample	532	1,481	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	453	1,289	$8
83615	Lactate dehydrogenase (enzyme) level	258	410	$6
84550	Uric acid level, blood	258	410	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Procrit	Epoetin Alfa	245	3,178	$254,419
Evenity (2 Syringes)	Romosozumab-Aqqg	100	2,800	$239,783
Revlimid	Lenalidomide	17	476	$236,465
Ibrance	Palbociclib	13	364	$201,963
Braftovi	Encorafenib	13	375	$193,291

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	14	$769

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$370	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$10,900	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Cynthia L. Shepherd, MD?

Tedicare shows public-source Medicare data for Cynthia L. Shepherd, MD (NPI 1730236688), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cynthia L. Shepherd, MD have ACO affiliation data?

Cynthia L. Shepherd, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Cynthia L. Shepherd, MD?

Cynthia L. Shepherd, MD is linked to UNIVERSITY CANCER & BLOOD CENTER LLC (billing NPI 1346343761) in the available physician profile data.

Does Cynthia L. Shepherd, MD have Open Payments data?

Cynthia L. Shepherd, MD has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.